Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:01:34.825Z.
Calculation as of: 2026-10-06T12:01:34.825Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0793561984d12013d5f07d0ccc5da74adc08ebcd6005adbeade30d207b80f537
EARNINGS YIELD
N/A
Cognition Therapeutics, Inc.
Market Cap
$83.96M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.70M
Earnings Yield
N/A
TTM Avg
39.78%
3Y Avg
39.78%
5Y Avg
39.78%
Market Cap
$84.75M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cognition Therapeutics, Inc. (CGTX) | $83.96M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | N/A | 39.78% | 39.78% | 39.78% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 3.42% | 2.77% | 2.77% | 8.10% |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.33M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.68M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
